THBI Welcomes U.S. Advanced Research Projects Agency (ARPA-H) to Texas

AUSTIN, TX – September 27, 2023 –The Texas Healthcare & Bioscience Institute (THBI) is thrilled to welcome the Advanced Research Projects Agency for Health (ARPA-H) to the Lone Star State. This new U.S. Department of Health and Human Services (HHS) agency is a nationwide health innovation network that will support transformative biomedical and health breakthroughs. 

View Press Release

THBI Announces Luminary Award Recipients

AUSTIN, TX - The Texas Healthcare and Bioscience Institute (THBI) will host its annual Fall Policy Summit and Luminary Awards Dinner Wednesday, October 25 at the Stephen F. Austin Hotel in downtown Austin. Each year, THBI’s membership nominates individuals who have had an impact on the life science and biotech community through policy, advocacy, and research. This year, the membership has selected Texas State Senator Royce West, Texas State Representative Angie Chen Button and Wayne Roberts, CEO of the Cancer Prevention and Research Institute (CPRIT) to receive the organization’s highest honors. 

View Press Release

New Report Examines the Bioscience Industry’s Economic Performance Nationally and in Texas

AUSTIN, TX – November 1, 2022 –The Texas Healthcare & Bioscience Institute (THBI), the trade association for the life science, bioscience and biotech industry in Texas, is thrilled to share the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations’ (CSBA) new data on the bioscience industry in the United States and specifically in Texas.

View Press Release
View National Report
View Texas Snapshot

THBI Hosts Annual Policy Summit and Awards Dinner with Impressive Speaker Line Up

AUSTIN, TX – October 7, 2022 - The Texas Healthcare and Bioscience Institute (THBI) will host its annual Fall Policy Summit and Luminary Awards Dinner Thursday, October 20 at the Stephen F. Austin Hotel in downtown Austin. 

View Press Release

THBI Names New Director of Policy

AUSTIN, TX - September 26, 2022 – The Texas Healthcare and Bioscience Institute (THBI) is pleased to welcome Danielle Lobsinger Bush as the new Director of Policy. Lobsinger Bush, as Director of Policy, will play a key role in advocating on issues important to the life science and bioscience industry in Texas at both the state and federal level.

View Press Release

MADE in America Act is Critical for the Pharmaceutical Industry

DALLAS, TX - September 24, 2022 The last couple of years are ripe with many lessons. From education to healthcare access to supply chains, America has had to revisit and revamp the way we work, learn and do business. We’ve also been confronted with the challenges of our global interdependence.

View Op-Ed

U.S. Medical Progress is in Jeopardy

DALLAS, TX - April 16, 2022 - Every day patients from around the country arrive in North Texas desperate for help, anxious for answers and hopeful for a cure. They come here for world-class medical treatment and to participate in one of the many clinical trials underway for a range of diseases from Alzheimer’s to cancer.

View Op-Ed

Texas Can Take Action to Lower Prescription Drug Costs 

LONGVIEW, TX - April 9, 2022 – Picture this next time you visit a restaurant. The kitchen makes the food and a waiter delivers the dish to your table, but with an added complexity: the waiter negotiated the cost of your enchilada plate with the kitchen, and you’ll learn the price when you receive the check.

View Op-Ed

THBI Names New Director of Operations and Economic Development

AUSTIN, TX - March 29, 2022 – The Texas Healthcare and Bioscience Institute (THBI) is welcoming Miranda Goodsheller as its new Director of Operations and Economic Development.  Goodsheller will be the organization’s first team member to focus not only on operational success but also on enhancing THBI’s economic development initiatives that support the growing Texas life science industry.

View Press Release

Study: Middlemen Drive the Cost of Brand Name Medicines

AUSTIN, TX, January 27, 2022 – An updated study from the Berkeley Research Group (BRG) shows more than half (50.5 percent) of total spending on brand-name prescription drugs goes to middlemen like pharmacy benefit managers (PBMs) and other stakeholders in the drug supply chain – not to drug manufacturers.

View Press Release
View Report

THBI Names New President and CEO

AUSTIN, TX - December 7, 2021 – The Texas Healthcare and Bioscience Institute (THBI) is welcoming Victoria Ford as its new President and CEO. Ford will be the organization’s second head executive following the retirement of Thomas Kowalski, who served as THBI’s President and CEO since its inception 25 years ago. Kowalski announced his retirement in August.

View Press Release